文献速递甲状腺疾病

21三体综合征儿童和青少年的甲状腺功能检查:综合征特异性参考范围的界定

Thyroid Function Tests in Children and Adolescents With Trisomy 21: Definition of Syndrome-Specific Reference Ranges.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

这项回顾性、单中心、观察性分析纳入548例0-18岁唐氏综合征患者,纵向评估1992年至2022年的甲状腺功能检查。研究建立了年龄依赖的TSH、FT3和FT4分布及列线图,发现TSH中位数在各年龄均显著高于非综合征儿童,TSH随时间波动明显,第75百分位是预测未来进展为显性甲状腺功能减退的最佳阈值。

要点

  • 唐氏综合征儿童TSH中位数在各年龄均显著高于非综合征儿童(P < .001)。
  • FT3中位数仅在0-11岁、FT4中位数仅在11-18岁显著低于对照组(P < .001)。
  • TSH第75百分位预测显性甲状腺功能减退的阴性预测值为0.91,阳性预测值为0.15。

核心结论

  • 通过纵向评估广泛的唐氏综合征儿科人群的甲状腺功能检查,研究勾勒出TSH、FT3和FT4的综合征特异性参考列线图,并证明TSH相较于非综合征儿童持续向上偏移。

研究设计与样本

  • 回顾性、单中心、观察性分析,纳入548例0-18岁唐氏综合征患者,纵向评估时间范围为1992年至2022年。
  • 排除标准为甲状腺解剖异常、影响甲状腺功能检查的治疗以及甲状腺自身抗体阳性。

主要发现

  • 确定了TSH、FT3和FT4的年龄依赖分布,并勾勒出唐氏综合征儿童的相对列线图。
  • 与非综合征患者相比,TSH中位数在任何年龄均统计学显著更高(P < .001)。
  • FT3中位数仅在0-11岁年龄组、FT4中位数仅在11-18岁年龄组统计学显著低于对照组(P < .001)。
  • TSH水平随时间显示显著波动,两次连续评估中TSH百分位类别之间的一致性较差(23%-53%)。
  • 第75百分位是TSH值预测未来进展为显性甲状腺功能减退的最佳统计准确性阈值,阴性预测值为0.91,阳性预测值为0.15。

关键数值与推荐

  • TSH中位数在唐氏综合征儿童中高于非综合征儿童,P < .001。
  • FT3中位数在0-11岁唐氏综合征儿童中低于对照组,P < .001。
  • FT4中位数在11-18岁唐氏综合征儿童中低于对照组,P < .001。
  • TSH第75百分位预测显性甲状腺功能减退的阴性预测值为0.91,阳性预测值为0.15。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The lack of syndrome-specific reference ranges for thyroid function tests (TFT) among pediatric patients with Down syndrome (DS) results in an overestimation of the occurrence of hypothyroidism in this population. OBJECTIVE: To (a) outline the age-dependent distribution of TFT among pediatric patients with DS; (b) describe the intraindividual variability of TFT over time; and (c) assess the role of elevated thyrotropin (TSH) in predicting the future onset of overt hypothyroidism. METHODS: In this retrospective, monocentric, observational analysis, we included 548 patients with DS (0-18 years) longitudinally assessed between 1992 and 2022. Exclusion criteria were abnormal thyroid anatomy, treatments affecting TFT, and positive thyroid autoantibodies. RESULTS: We determined the age-dependent distribution of TSH, FT3, and FT4 and outlined the relative nomograms for children with DS. Compared with non-syndromic patients, median TSH levels were statistically greater at any age (P < .001). Median FT3 and FT4 levels were statistically lower than controls (P < .001) only in specific age classes (0-11 for FT3, 11-18 years for FT4). TSH levels showed a remarkable fluctuation over time, with a poor (23%-53%) agreement between the TSH centile classes at 2 sequential assessments. Finally, the 75th centile was the threshold above which TSH values predicted future evolution into overt hypothyroidism with the best statistical accuracy, with a satisfactory negative predictive value (0.91), but poor positive predictive value (0.15). CONCLUSION: By longitudinally assessing TFT in a wide pediatric DS population, we outlined the syndrome-specific reference nomograms for TSH, FT3, and FT4 and demonstrated a persistent upward shift of TSH compared to non-syndromic children.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Cattoni A, Molinari S, Capitoli G, et al. Thyroid Function Tests in Children and Adolescents With Trisomy 21: Definition of Syndrome-Specific Reference Ranges. J Clin Endocrinol Metab. 2023. PMID: 37279507. doi:10.1210/clinem/dgad333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。